Proximagen and Upsher-Smith sign tonabersat deal
This article was originally published in Scrip
Executive Summary
Proximagen Neuroscience has signed a development, licence and sub-licence agreement with Upsher-Smith Laboratories in relation to tonabersat, which was recently acquired by Proximagen through its acquisition of Minster Pharmaceuticals.